3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Genitourinary
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
32
Leukemia
17
Leukemia, Myeloid, Chronic-Phase
16
Leukemia, Myeloid, Acute
14
Breast Neoplasms
12
Recurrence
11
Leukemia, Lymphocytic, Chronic, B-Cell
10
Prostatic Neoplasms
9
Neoplasm Metastasis
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
7
Blast Crisis
7
Pancreatic Neoplasms
6
Burkitt Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Multiple Myeloma
5
Lymphoma, Non-Hodgkin
5
Glioma
5
Glioblastoma
5
Philadelphia Chromosome
4
Myelodysplastic Syndromes
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma
4
Leukemia, Myeloid, Accelerated Phase
4
Gliosarcoma
4
Gastrointestinal Stromal Tumors
4
Colorectal Neoplasms
4
Waldenstrom Macroglobulinemia
3
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
testosterone undecanoate
1
Sirolimus
1
Nelfinavir
1
Metformin
1
Hydroxychloroquine
1
Gonadotropins
1
Diet, Protein-Restricted
1
Dasatinib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostate Cancer Recurrent
×
Dasatinib
×
Clear all
NCT05036226
2026-05-13
COAST
Medical University of South Carolina
Phase 1/2
Recruiting
76 enrolled